Background Drugs prescribed for psychiatric disorders in adolescence should be studied
very extensively since they can affect developing and thus highly plastic brain differently …

This report evaluates the effects of chlordiazepoxide, a benzodiazepine commonly
prescribed to manage anxiety-related disorders in adolescent/pediatric populations, on …

Background Ketamine (KET) is administered to manage major depression in adolescent
patients. However, the long-term effects of juvenile KET exposure on memory-related tasks …

The antidepressant medication fluoxetine (FLX) is frequently prescribed for the management
of mood‐related illnesses in the adolescent population—yet its long‐term neurobehavioral …

Background: Fluoxetine (FLX) represents the antidepressant of choice for the management
of pediatric mood-related illnesses. Accumulating preclinical evidence suggests that …

In rodents, early-life exposure to environmental stress or antidepressant medication
treatment has been shown to induce similar long-term consequences on memory-and …

Anxiety-related illnesses constitute one of the leading causes of disability across the globe.
Consequently, the need for validated preclinical models to uncover the etiology of anxiety …

Historically, animal models have been routinely used in the characterization of novel
chemical entities (NCEs) for various psychiatric disorders. Animal models have been …

There has been a disproportionate increase in fluoxetine (FLX) prescription rates within the
juvenile population. Thus, we evaluated how adolescent FLX exposure alters expression …

Stable and positive social bonds are pretty vital to the development of animals. Instability
and disruptions of social bonds, such as maternal separation and social isolation, always …